Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Factors predicting course of beta-cell function in IDDM.

A Schiffrin1, S Suissa, G Weitzner

  • 1Division of Endocrinology and Metabolism, Montreal Children's Hospital, Quebec, Canada.

Diabetes Care
|August 1, 1992
PubMed
Summary

Younger age, male sex, and presence of islet cell antibodies (ICA) predict faster loss of insulin secretion in children with type 1 diabetes. These factors accelerate C-peptide decline, impacting disease progression.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pioglitazone and bladder cancer: improving research methods.

Diabetic medicine : a journal of the British Diabetic Association·2020
Same author

Dysregulated liver lipid metabolism and innate immunity associated with hepatic steatosis in neonatal BBdp rats and NOD mice.

Scientific reports·2019
Same author

A systematic review of observational studies of the association between pioglitazone use and bladder cancer.

Diabetic medicine : a journal of the British Diabetic Association·2018
Same author

An orthologous non-MHC locus in rats and mice is linked to CD4<sup>+</sup> and CD8<sup>+</sup> T-cell proportion.

Genes and immunity·2017
Same author

Drospirenone-containing oral contraceptive pills and the risk of venous thromboembolism: a systematic review of observational studies.

BJOG : an international journal of obstetrics and gynaecology·2017
Same author

Cardiotoxicity of aromatase inhibitors and tamoxifen in postmenopausal women with breast cancer: a systematic review and meta-analysis of randomized controlled trials.

Annals of oncology : official journal of the European Society for Medical Oncology·2016

Area of Science:

  • Endocrinology
  • Immunology
  • Pediatrics

Background:

  • Type 1 diabetes (T1D) is an autoimmune disease characterized by the destruction of insulin-producing beta cells.
  • Residual insulin secretion, measured by C-peptide levels, is a key indicator of beta cell function and disease progression in T1D.
  • Predictors of the rate of C-peptide decline are crucial for understanding T1D heterogeneity and developing targeted interventions.

Purpose of the Study:

  • To investigate whether clinical presentation severity, sex, age, HLA type, and the presence of islet-associated antibodies (IAs) and islet cell antibodies (ICAs) predict residual insulin secretion.
  • To analyze the variation in serum C-peptide response to a Sustacal meal as a measure of insulin secretion.

Main Methods:

  • Prospective follow-up of 151 newly diagnosed T1D children for 3 years.

Related Experiment Videos

  • Measurement of serum C-peptide response to a Sustacal meal.
  • Analysis of clinical data including age, sex, symptom duration, clinical presentation severity, HLA type, and ICA titers.

    • Main Results:

    • Age, sex, ICA presence, clinical presentation severity, and symptom duration significantly predicted the rate of C-peptide secretion loss.
    • Accelerated C-peptide decline was associated with younger age, male sex, and the presence of ICA.
    • Older age groups showed a decreased risk of accelerated C-peptide disappearance.
    • A significant negative correlation was observed between ICA titers and C-peptide levels at 18 and 24 months post-diagnosis.

    Conclusions:

    • Younger age of onset, male sex, high ICA titers, severe clinical presentation, and shorter symptom duration are significant predictors of accelerated C-peptide secretion loss.
    • These factors contribute to the heterogeneity in T1D progression and beta cell destruction rates.